콘텐츠로 건너뛰기
SOLUTIONS
Drug Discovery Sevices
Collaboration Partners
Platform
R&D
Platform Technology
Pipelines
Publications
Patent & Cert.
ABOUT US
Overview
History
Partnership
CI & BI
NEWS
Press Release
Seminars & Events
Notice
Responsibility
CAREER
Menu
SOLUTIONS
Drug Discovery Sevices
Collaboration Partners
Platform
R&D
Platform Technology
Pipelines
Publications
Patent & Cert.
ABOUT US
Overview
History
Partnership
CI & BI
NEWS
Press Release
Seminars & Events
Notice
Responsibility
CAREER
Get In Touch
PharmCADD signed a collaborative research contract for innovative new drug development with NeuroVenti for Autism.
News
07/07/2021
<View Original Article>
Post Views:
134
Prev
Previous
PharmCADD moved into Cambridge Innovation Center (CIC) in Boston, USA.
Next
PharmCADD signed partnership for preparing KOSDAQ listing in next year with Korea Investment & Securities
Next